Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2656 of 3330
Next
>>
>
66376 to 66400 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.0000853	uM	5901.069	1.0277	1.0327	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	5901.069	0.9917	0.9901	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	5901.069	0.9272	0.9122	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	5901.069	0.7709	0.7138	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	5901.069	0.6529	0.5528	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	5901.069	0.6065	0.4864	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	5901.069	0.5835	0.4526	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	5901.069	0.5457	0.3959	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	5901.069	0.5138	0.3469	1.6847
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.000427	uM	9035.068	0.9258	0.9292	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.00213	uM	9035.068	0.9694	0.9711	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.0107	uM	9035.068	0.6443	0.6285	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.0533	uM	9035.068	0.5440	0.5047	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	0.267	uM	9035.068	0.5222	0.4761	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	1.33	uM	9035.068	0.4933	0.4374	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	6.67	uM	9035.068	0.5449	0.5058	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	33.3	uM	9035.068	0.5208	0.4743	2.1391
AU565	HER2amp	Luminal	Sirolimus	MTOR	MTOR	167	uM	9035.068	0.3671	0.2520	2.1391
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0000853	uM	5902.069	1.0019	1.0033	1.1199
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.000427	uM	5902.069	0.9773	0.9595	1.1199
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.00213	uM	5902.069	0.8906	0.8034	1.1199
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0107	uM	5902.069	0.7491	0.5453	1.1199
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.0533	uM	5902.069	0.7012	0.4567	1.1199
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	0.267	uM	5902.069	0.7027	0.4596	1.1199
BT-20	TNBC	Basal A	Sirolimus	MTOR	MTOR	1.33	uM	5902.069	0.6922	0.4401	1.1199

|<
<<
Previous
Page 2656 of 3330
Next
>>
>
66376 to 66400 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)